Recently incorporated into the list of procedures by the National Health Agency (ANS), Lenvima (lenvatinib mesylate ) is the new medication for thyroid cancer intended for patients who have already undergone radioiodine therapy and were unsuccessful
USP was part of the team that prepared the first Brazilian Oncological Guide , which provides recommendations for cancer prevention and control and reduction of mortality through regular physical activity. Produced by researchers from renowned instit
a theoretical modeling of physics helped a group of researchers in designing a new therapeutic approach that reduces the expression of a network of tumor metastases signals. The strategy, which uses low doses of multiple drugs, reduced the compensato